Junior Life Science Consultant at Kvalito Consulting Group, working on a project focused on Computerized Systems Validation and Cell & Gene Therapies for Novartis. Committed to providing the following services:- Managing Validation of spreadsheets critical for medicinal product production used in different production sites throughout Europe- Development of Computerized Systems Validation strategies and Validation Master Plans- Business analysis of Cell & Gene ATMP medicinal… Show more Junior Life Science Consultant at Kvalito Consulting Group, working on a project focused on Computerized Systems Validation and Cell & Gene Therapies for Novartis. Committed to providing the following services:- Managing Validation of spreadsheets critical for medicinal product production used in different production sites throughout Europe- Development of Computerized Systems Validation strategies and Validation Master Plans- Business analysis of Cell & Gene ATMP medicinal products development Show less

Junior researcher in the laboratory of Neurobiology of the IRCCS hospital San Camillo in Venezia, Italy. Performing molecular biology analysis (ELISA, western blot, nucleic acid extraction) on blood samples of patients of the hospital.

Development of CAR T immunotherapy strategies against Acute Myeloid Leukemia. Production of viral vectors for T cell transduction and follow-up analysis for quantitative and qualitative evaluation of viral products. Routine experiments including cell cultures and molecular biology assays.

Working as a master thesis student in the lab of Professor Nicola Vannini at Ludwig institute for Cancer Research in Lausanne, Switzerland.Involved in a cancer immunology project, performed my own experiments with murine cell cultures autonomously and mastered the use of analysis software in the field of immunology

Assessed the expression of pluripotency and differentiation markers of induced pluripotent stem cells (iPSCs) obtained from blood of a Parkinson’s disease affected patient.Engaged in research laboratory using induced Pluripotent Stem Cells as a tool to treat neurodegenerative diseases.Completed cell plating with supplementation of dedifferentiation markers in the media and molecular analysis on cells (PCR, RNA extraction, Real-Time PCR) and fluorescence microscopy observations